Afsar Ahammed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Afsar Ahammed has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Saifuddin
Associate professor, Department of Endocrinology, Dhaka Medical College Hospital, Dhaka, Bangladesh
5 shared publications - Firoj Hossain
Assistant professor, Department of Endocrinology, Dhaka Medical College Hospital, Dhaka, Bangladesh
4 shared publications - Shahjada Selim
Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
4 shared publications - Marufa Mustari
Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
3 shared publications - Mirza Sharifuzzaman
Associate professor, Department of Endocrinology, Dhaka Medical College Hospital, Dhaka, Bangladesh
3 shared publications - Mohammad Abdul Hannan
Department of Endocrinology, North East Medical College & Hospital, Sylhet, 3100, Bangladesh
3 shared publications
Latest Publications
- 9 July 2026
- Published by Bangladesh Academy of Sciences in Journal of Paediatric Surgeons of Bangladesh
- Vol. 17 (1) , 78-82
Risk Factors for Seizure Recurrence in Children with Febrile Seizures
Background: Febrile seizures happen in children between 6 months and 5 years with fever, impacting 2%–5%, and about one-third recur, typically within 1–2 years. They are categorized as either simple or complex. Recurrence is associated with factors like early onset age, family background, reduced fever intensity, and brief fever duration. This study seeks to pinpoint significant risk factors for recurrence to enhance management and guidance. Methods: This observational study conducted in a hospital involved 35 children between 6 months and 5 years who were clinically diagnosed with febrile seizures in the department of Emergency, Observation & Referral, Bangladesh Shishu Hospital & Institute. Clinical, demographic, and laboratory data were analysed using SPSS v25.0 to determine predictors of recurrence, with ethical approval and informed consent secured. Results: Out of 35 children experiencing febrile seizures, 34.3% experienced a recurrence. Younger age (<2 years), a family history, brief fever duration (<24 hours), and multiple seizures occurring within 24 hours were significant predictors (p<0.05). Logistic regression indicated higher odds of recurrence for age under 2 years (OR=2.8), a family history (OR=3.5), fever lasting less than 24 hours (OR=2.9), and multiple seizures (OR=3.8), with hyponatremia demonstrating borderline significance. Conclusion: Recurrent febrile seizures were common and associated with younger age, a family history, brief fever duration, and several seizures occurring within a 24-hour period. There was also a connection to extended seizures and low sodium levels. These elements assist in evaluating risks and providing guidance, with additional extensive studies required for validation. Journal of Paediatric Surgeons of Bangladesh (2026) Vol. 17 (1): 78-82
- 9 July 2026
- Published by Bangladesh Academy of Sciences in Journal of Paediatric Surgeons of Bangladesh
- Vol. 17 (1) , 78-82
Risk Factors for Seizure Recurrence in Children with Febrile Seizures
Background: Febrile seizures happen in children between 6 months and 5 years with fever, impacting 2%–5%, and about one-third recur, typically within 1–2 years. They are categorized as either simple or complex. Recurrence is associated with factors like early onset age, family background, reduced fever intensity, and brief fever duration. This study seeks to pinpoint significant risk factors for recurrence to enhance management and guidance. Methods: This observational study conducted in a hospital involved 35 children between 6 months and 5 years who were clinically diagnosed with febrile seizures in the department of Emergency, Observation & Referral, Bangladesh Shishu Hospital & Institute. Clinical, demographic, and laboratory data were analysed using SPSS v25.0 to determine predictors of recurrence, with ethical approval and informed consent secured. Results: Out of 35 children experiencing febrile seizures, 34.3% experienced a recurrence. Younger age (<2 years), a family history, brief fever duration (<24 hours), and multiple seizures occurring within 24 hours were significant predictors (p<0.05). Logistic regression indicated higher odds of recurrence for age under 2 years (OR=2.8), a family history (OR=3.5), fever lasting less than 24 hours (OR=2.9), and multiple seizures (OR=3.8), with hyponatremia demonstrating borderline significance. Conclusion: Recurrent febrile seizures were common and associated with younger age, a family history, brief fever duration, and several seizures occurring within a 24-hour period. There was also a connection to extended seizures and low sodium levels. These elements assist in evaluating risks and providing guidance, with additional extensive studies required for validation. Journal of Paediatric Surgeons of Bangladesh (2026) Vol. 17 (1): 78-82
- Open Access
- 8 March 2026
- Published by Bangladesh Academy of Sciences in Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh
- Vol. 5 (2) , e88864
Socio-demographic characteristics, clinical pattern, and mental health status of gender dysphoria patients in a tertiary care hospital of Bangladesh
Background: Gender dysphoria is characterized by marked incongruence between the assigned gender at birth and the experienced gender, leading to significant emotional distress affecting mental health, social interactions, and overall well-being. In Bangladesh, published data on patients with gender dysphoria remain scarce, and persistent social stigma, discrimination, and barriers to care continue to affect timely help-seeking and access to appropriate psychological support. Objectives: To determine the socio-demographic characteristics, clinical pattern, and mental health status of patients with gender dysphoria. Methods: This cross-sectional study was conducted at the Department of Endocrinology, Dhaka Medical College Hospital, from January to December 2024. Fifty patients with gender dysphoria were enrolled using purposive sampling. Participants underwent a detailed assessment, including socio-demographic characteristics, clinical pattern evaluation, and mental health status assessment using the validated Bangla version of the Depression Anxiety Stress Scale-21 (DASS-21). Data were analyzed using Statistical Package for Social Sciences (SPSS) version 27 (IBM Corp., Armonk, NY). Results: The mean age was 26.16±9.99 years, with most participants being students (48%) and single (84%). Mean age of onset of gender dysphoria was 13.56±7.38 years, while first consultation occurred at 22.36±7.98 years. Among participants, 66% assigned male at birth identified as female, 96% engaged in cross-dressing, 44% received psychotherapy, 24% underwent hormone therapy, and 14% had gender reassignment surgery. Mental health assessment revealed 78% had depression (ranging from mild to severe), 72% experienced moderate to severe anxiety, and 40% reported suicide attempts. Conclusions: Gender dysphoria patients in Bangladesh demonstrate a significant mental health burden with high rates of depression, anxiety, and suicidal behavior. Early recognition and timely multidisciplinary care, with psychotherapy and psychosocial support at its core, are essential to address mental health needs in this vulnerable population. [J Assoc Clin Endocrinol Diabetol Bangladesh, July 2026; 5 (2): e88864]
- 8 March 2026
- Published by Bangladesh Academy of Sciences in Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh
- Vol. 5 (2) , e88864
Open AccessSocio-demographic characteristics, clinical pattern, and mental health status of gender dysphoria patients in a tertiary care hospital of Bangladesh
Background: Gender dysphoria is characterized by marked incongruence between the assigned gender at birth and the experienced gender, leading to significant emotional distress affecting mental health, social interactions, and overall well-being. In Bangladesh, published data on patients with gender dysphoria remain scarce, and persistent social stigma, discrimination, and barriers to care continue to affect timely help-seeking and access to appropriate psychological support. Objectives: To determine the socio-demographic characteristics, clinical pattern, and mental health status of patients with gender dysphoria. Methods: This cross-sectional study was conducted at the Department of Endocrinology, Dhaka Medical College Hospital, from January to December 2024. Fifty patients with gender dysphoria were enrolled using purposive sampling. Participants underwent a detailed assessment, including socio-demographic characteristics, clinical pattern evaluation, and mental health status assessment using the validated Bangla version of the Depression Anxiety Stress Scale-21 (DASS-21). Data were analyzed using Statistical Package for Social Sciences (SPSS) version 27 (IBM Corp., Armonk, NY). Results: The mean age was 26.16±9.99 years, with most participants being students (48%) and single (84%). Mean age of onset of gender dysphoria was 13.56±7.38 years, while first consultation occurred at 22.36±7.98 years. Among participants, 66% assigned male at birth identified as female, 96% engaged in cross-dressing, 44% received psychotherapy, 24% underwent hormone therapy, and 14% had gender reassignment surgery. Mental health assessment revealed 78% had depression (ranging from mild to severe), 72% experienced moderate to severe anxiety, and 40% reported suicide attempts. Conclusions: Gender dysphoria patients in Bangladesh demonstrate a significant mental health burden with high rates of depression, anxiety, and suicidal behavior. Early recognition and timely multidisciplinary care, with psychotherapy and psychosocial support at its core, are essential to address mental health needs in this vulnerable population. [J Assoc Clin Endocrinol Diabetol Bangladesh, July 2026; 5 (2): e88864]
- Open Access
- 1 February 2026
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 19, 1-16
Real-World Effectiveness and Safety of Imeglimin in Type 2 Diabetes: Prospective Multi-Center Study in Bangladesh
Background: This study assessed the real-world effectiveness and safety of imeglimin among Bangladeshi patients with type 2 diabetes mellitus (T2DM). Methods: This prospective, multi-center observational study was conducted across 15 specialized diabetes care centers in Bangladesh from January 2024 to December 2024. Adults with uncontrolled T2DM (HbA1c > 7%) prescribed imeglimin (500– 2000 mg daily) either as monotherapy or combination therapy were enrolled. A total of 898 subjects were assessed at baseline, 3 months, and 6 months. Primary outcomes were changes in HbA1c, fasting plasma glucose (FPG), and postprandial plasma glucose (PPPG). Secondary outcomes included body mass index (BMI), blood pressure, lipids, and safety parameters. Results: The mean age was 46.2 ± 13.1 (SD) years, with 67% being female. Baseline HbA1c decreased from 9.2± 1.4% to 7.1± 1.0% at 6 months (mean change: − 2.1%, p< 0.001). FPG reduced from 9.37± 2.53 to 7.28± 4.63 mmol/L (p< 0.001) and PPPG from 14.36± 3.29 to 8.95± 1.76 mmol/L (p< 0.001). BMI decreased from 28.1± 4.2 to 25.6± 3.6 kg/m2 (p< 0.001). Significant improvements occurred in blood pressure, lipids, and renal parameters. Adverse events were mild; 3.6% reported ≥ 1 event (gastrointestinal 2.4%, dehydration 1.3%). No serious adverse events occurred. Conclusion: Imeglimin demonstrated substantial glycemic improvements and favorable safety in real-world Bangladeshi patients with poor glycemic control.
- 1 February 2026
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 19, 1-16
Open AccessReal-World Effectiveness and Safety of Imeglimin in Type 2 Diabetes: Prospective Multi-Center Study in Bangladesh
Background: This study assessed the real-world effectiveness and safety of imeglimin among Bangladeshi patients with type 2 diabetes mellitus (T2DM). Methods: This prospective, multi-center observational study was conducted across 15 specialized diabetes care centers in Bangladesh from January 2024 to December 2024. Adults with uncontrolled T2DM (HbA1c > 7%) prescribed imeglimin (500– 2000 mg daily) either as monotherapy or combination therapy were enrolled. A total of 898 subjects were assessed at baseline, 3 months, and 6 months. Primary outcomes were changes in HbA1c, fasting plasma glucose (FPG), and postprandial plasma glucose (PPPG). Secondary outcomes included body mass index (BMI), blood pressure, lipids, and safety parameters. Results: The mean age was 46.2 ± 13.1 (SD) years, with 67% being female. Baseline HbA1c decreased from 9.2± 1.4% to 7.1± 1.0% at 6 months (mean change: − 2.1%, p< 0.001). FPG reduced from 9.37± 2.53 to 7.28± 4.63 mmol/L (p< 0.001) and PPPG from 14.36± 3.29 to 8.95± 1.76 mmol/L (p< 0.001). BMI decreased from 28.1± 4.2 to 25.6± 3.6 kg/m2 (p< 0.001). Significant improvements occurred in blood pressure, lipids, and renal parameters. Adverse events were mild; 3.6% reported ≥ 1 event (gastrointestinal 2.4%, dehydration 1.3%). No serious adverse events occurred. Conclusion: Imeglimin demonstrated substantial glycemic improvements and favorable safety in real-world Bangladeshi patients with poor glycemic control.
- Open Access
- 24 August 2025
- Published by Bangladesh Academy of Sciences in Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh
- Vol. 4 (2) , 90-95
Diagnostic challenges in precocious puberty: A case of a 7-year-old girl
Immune-mediated destruction of two or more endocrine glands results in a cluster of deficits in multiple glands, known as autoimmune polyglandular syndrome. Autoimmune hypothyroidism is a common presentation of autoimmune polyglandular syndrome type II (APS–II). Long-standing, untreated hypothyroidism may cause isosexual precocious puberty, which is termed Van Wyk Grumbach syndrome. A 7-year-old girl was diagnosed with autoimmune hypothyroidism and type 1A diabetes mellitus and hence termed as autoimmune polyglandular syndrome type II. She had a history of menarche at the age of 2 years and 6 months and presented with bilateral ovarian cysts and delayed bone age. She was treated with thyroxine along with insulin. Thyroxine therapy stopped her menstruation with a reduction of ovarian cyst size. J Assoc Clin Endocrinol Diabetol Bangladesh, July 2025;4(2): 90-95
- 24 August 2025
- Published by Bangladesh Academy of Sciences in Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh
- Vol. 4 (2) , 90-95
Open AccessDiagnostic challenges in precocious puberty: A case of a 7-year-old girl
Immune-mediated destruction of two or more endocrine glands results in a cluster of deficits in multiple glands, known as autoimmune polyglandular syndrome. Autoimmune hypothyroidism is a common presentation of autoimmune polyglandular syndrome type II (APS–II). Long-standing, untreated hypothyroidism may cause isosexual precocious puberty, which is termed Van Wyk Grumbach syndrome. A 7-year-old girl was diagnosed with autoimmune hypothyroidism and type 1A diabetes mellitus and hence termed as autoimmune polyglandular syndrome type II. She had a history of menarche at the age of 2 years and 6 months and presented with bilateral ovarian cysts and delayed bone age. She was treated with thyroxine along with insulin. Thyroxine therapy stopped her menstruation with a reduction of ovarian cyst size. J Assoc Clin Endocrinol Diabetol Bangladesh, July 2025;4(2): 90-95
- Open Access
- 5 December 2023
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 23 (1) , 1-9
Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study
Background: Achievement of lipid targets is crucial in patients with type 2 diabetes mellitus (T2DM) to mitigate the risk of cardiovascular diseases (CVD). Data on lipid-control status among patients with T2DM in Bangladesh are scarce. This study was conducted to determine the lipid-control status among patients with T2DM who were on lipid-lowering drugs in the country. Methods: This cross-sectional study was conducted in the diabetes outpatient departments of several tertiary hospitals in Bangladesh from January 2022 to December 2022. Adults of both sexes diagnosed with T2DM for at least one year and were on the lipid-lowering drug(s) for a minimum of 3 months were included in the study by consecutive sampling. Patients’ data were collected by face-to-face interviews, and blood samples were collected for fasting lipid profile. The lipid target was set at < 200 mg/dL for total cholesterol (TC), < 150 mg/dL for triglyceride (TG), < 100 mg/dL for low-density lipoprotein cholesterol (LDL-C), > 40 mg/dL for high-density lipoprotein cholesterol (HDL-C), and < 160 mg/dL for non-HDL cholesterol (non-HDL-C). Result: Three thousand sixty patients (age 44.7 ± 13.3 years, female 57%) with T2DM were evaluated. Overall, almost 81% of the study subjects achieved the LDL-C target. Besides, TC, TG, HDL-C, and non-HDL-C targets were achieved by 40.8, 21.6, 66.3, and 44.1% of patients, respectively. However, all the lipid parameters were under control in only 8.8% of patients. Almost 77.6% of the patients with ischemic heart disease, 81.5% of patients with stroke, and 65% of patients with CKD had LDL levels < 70 mg/dL. Only 10.03% achieved the HbA1c target of < 7%. 7.4% of patients achieved both HbA1c < 7% and LDL < 100 mg/dL and 5% achieved both HbA1c < 7% and LDL < 70 mg/dL. Advanced age (aOR 0.97, 95% CI 0.96, 0.98, p < 0.001), longstanding T2DM (aOR 0.53, 95% CI 0.39, 0.72, p < 0.001), and non-statin therapy (aOR 0.25, 95% CI 0.16, 0.37, p < 0.001) were negatively associated with lipid control (LDL < 100 mg/dL) while using oral hypoglycemic drugs or insulin (aOR 2.01, 95% CI 1.45, 2.77, p < 0.001) and having cardiovascular comorbidity (aOR 3.92, 95% CI 3.00, 5.12, p < 0.001) were positively associated with lipid control. Conclusion: Though most patients with T2DM achieved their target LDL level, the prevalence of both glycemic and overall lipid control was low in our study despite lipid-lowering therapy.
- 5 December 2023
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 23 (1) , 1-9
Open AccessStatus of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study
Background: Achievement of lipid targets is crucial in patients with type 2 diabetes mellitus (T2DM) to mitigate the risk of cardiovascular diseases (CVD). Data on lipid-control status among patients with T2DM in Bangladesh are scarce. This study was conducted to determine the lipid-control status among patients with T2DM who were on lipid-lowering drugs in the country. Methods: This cross-sectional study was conducted in the diabetes outpatient departments of several tertiary hospitals in Bangladesh from January 2022 to December 2022. Adults of both sexes diagnosed with T2DM for at least one year and were on the lipid-lowering drug(s) for a minimum of 3 months were included in the study by consecutive sampling. Patients’ data were collected by face-to-face interviews, and blood samples were collected for fasting lipid profile. The lipid target was set at < 200 mg/dL for total cholesterol (TC), < 150 mg/dL for triglyceride (TG), < 100 mg/dL for low-density lipoprotein cholesterol (LDL-C), > 40 mg/dL for high-density lipoprotein cholesterol (HDL-C), and < 160 mg/dL for non-HDL cholesterol (non-HDL-C). Result: Three thousand sixty patients (age 44.7 ± 13.3 years, female 57%) with T2DM were evaluated. Overall, almost 81% of the study subjects achieved the LDL-C target. Besides, TC, TG, HDL-C, and non-HDL-C targets were achieved by 40.8, 21.6, 66.3, and 44.1% of patients, respectively. However, all the lipid parameters were under control in only 8.8% of patients. Almost 77.6% of the patients with ischemic heart disease, 81.5% of patients with stroke, and 65% of patients with CKD had LDL levels < 70 mg/dL. Only 10.03% achieved the HbA1c target of < 7%. 7.4% of patients achieved both HbA1c < 7% and LDL < 100 mg/dL and 5% achieved both HbA1c < 7% and LDL < 70 mg/dL. Advanced age (aOR 0.97, 95% CI 0.96, 0.98, p < 0.001), longstanding T2DM (aOR 0.53, 95% CI 0.39, 0.72, p < 0.001), and non-statin therapy (aOR 0.25, 95% CI 0.16, 0.37, p < 0.001) were negatively associated with lipid control (LDL < 100 mg/dL) while using oral hypoglycemic drugs or insulin (aOR 2.01, 95% CI 1.45, 2.77, p < 0.001) and having cardiovascular comorbidity (aOR 3.92, 95% CI 3.00, 5.12, p < 0.001) were positively associated with lipid control. Conclusion: Though most patients with T2DM achieved their target LDL level, the prevalence of both glycemic and overall lipid control was low in our study despite lipid-lowering therapy.
- Open Access
- 26 June 2023
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 15 (1) , 1-9
Comparison of fasting and random lipid profiles among subjects with type 2 diabetes mellitus: an outpatient-based cross-sectional study in Bangladesh
Background: Despite the wide acceptability of fasting lipid profiles in practice, emerging evidence suggests that random lipid profiles might be a convenient alternative for lipid measurement. The objective of the present study was to compare the fasting and random lipid profile among subjects with type 2 diabetes mellitus (T2DM). Methods: The present cross-sectional study included 1543 subjects with T2DM visiting several endocrinology outpatient clinics throughout Bangladesh from January to December 2021. The fasting lipid profile was measured in the morning following 8–10 h of overnight fasting, and the random lipid profile was measured at any time of the day, irrespective of the last meal. The values of fasting and random lipids were compared using the Wilcoxon signed-rank test and Spearman rank correlation coefficients. Results: In this study, a good level of correlation was observed between fasting and random lipid levels [r = 0.793, p < 0.001 for triglyceride (TG); r = 0.873, p < 0.001 for low-density lipoprotein cholesterol (LDL-C); r = 0.609, p < 0.001 for high-density lipoprotein cholesterol (HDL-C); and r = 0.780, p < 0.001 for total cholesterol (TC)]. In addition, TG and TC levels increased by 14% and 0.51%, respectively, in the random state compared to the fasting state (p- <0.05), while LDL-C levels decreased by 0.71% (p-value 0.42). No change was noticed in the HDL-C level. The difference between fasting and random lipid profiles was similar irrespective of patients’ age, sex, BMI, glucose-lowering drug(s), and lipid-lowering therapy. Conclusions: Random lipid profile correlates significantly with fasting lipid profile with little difference. Hence, it might be a reliable alternative for fasting lipid profile in patients with T2DM.
- 26 June 2023
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 15 (1) , 1-9
Open AccessComparison of fasting and random lipid profiles among subjects with type 2 diabetes mellitus: an outpatient-based cross-sectional study in Bangladesh
Background: Despite the wide acceptability of fasting lipid profiles in practice, emerging evidence suggests that random lipid profiles might be a convenient alternative for lipid measurement. The objective of the present study was to compare the fasting and random lipid profile among subjects with type 2 diabetes mellitus (T2DM). Methods: The present cross-sectional study included 1543 subjects with T2DM visiting several endocrinology outpatient clinics throughout Bangladesh from January to December 2021. The fasting lipid profile was measured in the morning following 8–10 h of overnight fasting, and the random lipid profile was measured at any time of the day, irrespective of the last meal. The values of fasting and random lipids were compared using the Wilcoxon signed-rank test and Spearman rank correlation coefficients. Results: In this study, a good level of correlation was observed between fasting and random lipid levels [r = 0.793, p < 0.001 for triglyceride (TG); r = 0.873, p < 0.001 for low-density lipoprotein cholesterol (LDL-C); r = 0.609, p < 0.001 for high-density lipoprotein cholesterol (HDL-C); and r = 0.780, p < 0.001 for total cholesterol (TC)]. In addition, TG and TC levels increased by 14% and 0.51%, respectively, in the random state compared to the fasting state (p- <0.05), while LDL-C levels decreased by 0.71% (p-value 0.42). No change was noticed in the HDL-C level. The difference between fasting and random lipid profiles was similar irrespective of patients’ age, sex, BMI, glucose-lowering drug(s), and lipid-lowering therapy. Conclusions: Random lipid profile correlates significantly with fasting lipid profile with little difference. Hence, it might be a reliable alternative for fasting lipid profile in patients with T2DM.
- Open Access
- 24 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31889
Economic Burden of Severe Hypoglycemia Among Patients With Diabetes Mellitus
Background: Bangladesh is anticipated to have the eighth-highest number of diabetic patients within the next 15 years. Approximately one-fifth of adult diabetes patients reside in Southeast Asian nations. This study aimed to find out the economic burden of extreme hypoglycemia on diabetic sufferers in Bangladesh. Methods: A cross-sectional study was carried out amongst 164 Type 2 Diabetes sufferers admitted due to extreme hypoglycemia within 15 months at BIRDEM in Dhaka to decide if they have the impact of extreme hypoglycemia on the cost of illness. The cost was once expressed in BDT. Results: Direct medical cost (37058) and direct non-medical cost (5261) was estimated during the study. Among the direct medical cost, hospital cost was 17735, physician cost was 5745, nonmedical transport cost was 1802, and attendant cost was 3459. The total cost was 48743 BDT (€617) for each severe hypoglycemic event leading to hospitalization, and 6.4244 BDT (€82.4) would be the indirect cost of reduced productivity from spending 5.8 days (46.4 hours) in the hospital. Conclusion: The analysis indicates that hypoglycemia has a significant negative influence on the cost and reduces the work output of diabetics.
- 24 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31889
Open AccessEconomic Burden of Severe Hypoglycemia Among Patients With Diabetes Mellitus
Background: Bangladesh is anticipated to have the eighth-highest number of diabetic patients within the next 15 years. Approximately one-fifth of adult diabetes patients reside in Southeast Asian nations. This study aimed to find out the economic burden of extreme hypoglycemia on diabetic sufferers in Bangladesh. Methods: A cross-sectional study was carried out amongst 164 Type 2 Diabetes sufferers admitted due to extreme hypoglycemia within 15 months at BIRDEM in Dhaka to decide if they have the impact of extreme hypoglycemia on the cost of illness. The cost was once expressed in BDT. Results: Direct medical cost (37058) and direct non-medical cost (5261) was estimated during the study. Among the direct medical cost, hospital cost was 17735, physician cost was 5745, nonmedical transport cost was 1802, and attendant cost was 3459. The total cost was 48743 BDT (€617) for each severe hypoglycemic event leading to hospitalization, and 6.4244 BDT (€82.4) would be the indirect cost of reduced productivity from spending 5.8 days (46.4 hours) in the hospital. Conclusion: The analysis indicates that hypoglycemia has a significant negative influence on the cost and reduces the work output of diabetics.
- Open Access
- 1 January 2018
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 22 (4) , 499-504
The burden of severe hypoglycemia on quality of life among diabetes mellitus patients in a tertiary level hospital of Bangladesh
Objective: This study aimed to determine the impact of hypoglycemia on health-related quality of life from a patient perspective. Materials and Methods: A cross-sectional study was conducted in 164 type 2 diabetes patients admitted due to severe hypoglycemia from August 2015 to October 2016 at Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, in Dhaka. Impact of severe hypoglycemia on health-related quality of life in diabetic patients was evaluated using the disease-specific questionnaire audit of diabetes-dependent quality of life-19 (ADDQOL-19). Results: The median ADDQOL score was calculated at −3.31. Totally, 88 (53.7%) patients reported an ADDQOL score of − 3.31 or more, and 76 (46.3%) patients had an ADDQOL score of less than −3.31 (lower quality of life [QoL]). After considering weighting, “Freedom to eat” (mean Weighted Impact Score-6.32 ± 1.94) was the most and “Holidays” (mean Weighted Impact Score-0.96 ± 0.19) was the least affected QoL domains, respectively. In multivariate logistic regression analysis, severe hypoglycemia impact on ADDQOL was related with age (odds ratio [OR] 0.932, 95% confidence intervals [CIs] 0.897–0.969, P < 0.001), sex (OR 0.088, 95% CIs 0.023–0.338, P < 0.001), glycated hemoglobin (%) (OR 0.613, 95% CIs 0.422–0.890, P = 0.010), and marital status (OR 9.264, 95% CIs 2.467–34.790, P = 0.001). Conclusions: The results of this analysis suggest hypoglycemia impacts heavily on the well-being and quality of life of people with diabetes, and every effort should be made to minimize hypoglycemia while aiming for good glycemic control.
- 1 January 2018
- Published by Medknow in Indian Journal of Endocrinology and Metabolism
- Vol. 22 (4) , 499-504
Open AccessThe burden of severe hypoglycemia on quality of life among diabetes mellitus patients in a tertiary level hospital of Bangladesh
Objective: This study aimed to determine the impact of hypoglycemia on health-related quality of life from a patient perspective. Materials and Methods: A cross-sectional study was conducted in 164 type 2 diabetes patients admitted due to severe hypoglycemia from August 2015 to October 2016 at Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, in Dhaka. Impact of severe hypoglycemia on health-related quality of life in diabetic patients was evaluated using the disease-specific questionnaire audit of diabetes-dependent quality of life-19 (ADDQOL-19). Results: The median ADDQOL score was calculated at −3.31. Totally, 88 (53.7%) patients reported an ADDQOL score of − 3.31 or more, and 76 (46.3%) patients had an ADDQOL score of less than −3.31 (lower quality of life [QoL]). After considering weighting, “Freedom to eat” (mean Weighted Impact Score-6.32 ± 1.94) was the most and “Holidays” (mean Weighted Impact Score-0.96 ± 0.19) was the least affected QoL domains, respectively. In multivariate logistic regression analysis, severe hypoglycemia impact on ADDQOL was related with age (odds ratio [OR] 0.932, 95% confidence intervals [CIs] 0.897–0.969, P < 0.001), sex (OR 0.088, 95% CIs 0.023–0.338, P < 0.001), glycated hemoglobin (%) (OR 0.613, 95% CIs 0.422–0.890, P = 0.010), and marital status (OR 9.264, 95% CIs 2.467–34.790, P = 0.001). Conclusions: The results of this analysis suggest hypoglycemia impacts heavily on the well-being and quality of life of people with diabetes, and every effort should be made to minimize hypoglycemia while aiming for good glycemic control.
- Open Access
- 31 August 2017
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Infectious Diseases
- Vol. 3 (2) , 29-35
Living Pattern and Behavioral Risk Factors for Kala-azar: A Case-Control Study in Tertiary Care Hospital of Bangladesh
Background: There are many risk factors which can influence the causation of kala azar in Bangladeshi people. Objective: The aim of the present study is to describe the living pattern and behavioral risk factors of kala-azar among a case series of Bangladeshi patients. Method: This case control study was carried out at inpatient department of Community Based Medical College Hospital, Mymensingh from July 2010 to June 2011, for a period of 1(one) year. The study samples were clinically and parasitologically confirmed kala-azar cases. The controls were rK 39 strip test negative hospitalized cases admitted for other reason. Results: Univariate analysis showed that age, sex, marital status, average number of person living in room frequently, goat sharing in sleeping room, number of kala-azar treatment in living family members, nearest distance of known kala-azar, were risk factors. Multivariate analysis showed that Marital status (OR=6.940, 95%CI=2.710-17.772, P=.001), Number of family member living in the room were significant risk factors (OR=1.786, 95%CI=1.097-2.907, P=0.020) for kala-azar. Conclusion: These findings have important practical implications because they suggest that these measures, along with appropriate vector control and improved treatment facilities in rural areas, may be particularly effective in reducing the incidence of kala-azar and its transmission of infection by sand fly vectors. Bangladesh Journal of Infectious Diseases 2016;3(2):29-35
- 31 August 2017
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Infectious Diseases
- Vol. 3 (2) , 29-35
Open AccessLiving Pattern and Behavioral Risk Factors for Kala-azar: A Case-Control Study in Tertiary Care Hospital of Bangladesh
Background: There are many risk factors which can influence the causation of kala azar in Bangladeshi people. Objective: The aim of the present study is to describe the living pattern and behavioral risk factors of kala-azar among a case series of Bangladeshi patients. Method: This case control study was carried out at inpatient department of Community Based Medical College Hospital, Mymensingh from July 2010 to June 2011, for a period of 1(one) year. The study samples were clinically and parasitologically confirmed kala-azar cases. The controls were rK 39 strip test negative hospitalized cases admitted for other reason. Results: Univariate analysis showed that age, sex, marital status, average number of person living in room frequently, goat sharing in sleeping room, number of kala-azar treatment in living family members, nearest distance of known kala-azar, were risk factors. Multivariate analysis showed that Marital status (OR=6.940, 95%CI=2.710-17.772, P=.001), Number of family member living in the room were significant risk factors (OR=1.786, 95%CI=1.097-2.907, P=0.020) for kala-azar. Conclusion: These findings have important practical implications because they suggest that these measures, along with appropriate vector control and improved treatment facilities in rural areas, may be particularly effective in reducing the incidence of kala-azar and its transmission of infection by sand fly vectors. Bangladesh Journal of Infectious Diseases 2016;3(2):29-35